Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Medical Oncology
Interventions: DRUG: BAY1217389|DRUG: Paclitaxel
Sponsor: Bayer